These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 38315389)
1. A Mouse Model of Hepatocellular Carcinoma Induced by Streptozotocin and High-Fat Diet. Motiño O; Li S; Lambertucci F; Anagnostopoulos G; Montégut L; Nogueira-Recalde U; Chen H; Maiuri MC; Kroemer G; Martins I Methods Mol Biol; 2024; 2769():67-75. PubMed ID: 38315389 [TBL] [Abstract][Full Text] [Related]
2. Key features of the environment promoting liver cancer in the absence of cirrhosis. Zaki MYW; Mahdi AK; Patman GL; Whitehead A; Maurício JP; McCain MV; Televantou D; Abou-Beih S; Ramon-Gil E; Watson R; Cox C; Leslie J; Wilson C; Govaere O; Lunec J; Mann DA; Nakjang S; Oakley F; Shukla R; Anstee QM; Tiniakos D; Reeves HL Sci Rep; 2021 Aug; 11(1):16727. PubMed ID: 34408183 [TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice. Yokohama K; Fukunishi S; Ii M; Nakamura K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K Int J Mol Med; 2016 Nov; 38(5):1499-1506. PubMed ID: 28025996 [TBL] [Abstract][Full Text] [Related]
4. A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma. Fujii M; Shibazaki Y; Wakamatsu K; Honda Y; Kawauchi Y; Suzuki K; Arumugam S; Watanabe K; Ichida T; Asakura H; Yoneyama H Med Mol Morphol; 2013 Sep; 46(3):141-52. PubMed ID: 23430399 [TBL] [Abstract][Full Text] [Related]
5. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer. Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534 [TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet. Ikawa-Yoshida A; Matsuo S; Kato A; Ohmori Y; Higashida A; Kaneko E; Matsumoto M Int J Exp Pathol; 2017 Aug; 98(4):221-233. PubMed ID: 28895242 [TBL] [Abstract][Full Text] [Related]
7. A Mouse Model of Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma Induced by Western Diet and Carbon Tetrachloride. Li S; Motiño O; Lambertucci F; Chen H; Anagnostopoulos G; Montégut L; Nogueira-Recalde U; Maiuri MC; Kroemer G; Martins I Methods Mol Biol; 2024; 2769():57-65. PubMed ID: 38315388 [TBL] [Abstract][Full Text] [Related]
8. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675 [TBL] [Abstract][Full Text] [Related]
10. A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma. Jeong BK; Choi WI; Choi W; Moon J; Lee WH; Choi C; Choi IY; Lee SH; Kim JK; Ju YS; Kim P; Moon YA; Park JY; Kim H Nat Commun; 2024 Aug; 15(1):6506. PubMed ID: 39090079 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice. Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044 [TBL] [Abstract][Full Text] [Related]
12. Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling. Kotsiliti E; Leone V; Schuehle S; Govaere O; Li H; Wolf MJ; Horvatic H; Bierwirth S; Hundertmark J; Inverso D; Zizmare L; Sarusi-Portuguez A; Gupta R; O'Connor T; Giannou AD; Shiri AM; Schlesinger Y; Beccaria MG; Rennert C; Pfister D; Öllinger R; Gadjalova I; Ramadori P; Rahbari M; Rahbari N; Healy ME; Fernández-Vaquero M; Yahoo N; Janzen J; Singh I; Fan C; Liu X; Rau M; Feuchtenberger M; Schwaneck E; Wallace SJ; Cockell S; Wilson-Kanamori J; Ramachandran P; Kho C; Kendall TJ; Leblond AL; Keppler SJ; Bielecki P; Steiger K; Hofmann M; Rippe K; Zitzelsberger H; Weber A; Malek N; Luedde T; Vucur M; Augustin HG; Flavell R; Parnas O; Rad R; Pabst O; Henderson NC; Huber S; Macpherson A; Knolle P; Claassen M; Geier A; Trautwein C; Unger K; Elinav E; Waisman A; Abdullah Z; Haller D; Tacke F; Anstee QM; Heikenwalder M J Hepatol; 2023 Aug; 79(2):296-313. PubMed ID: 37224925 [TBL] [Abstract][Full Text] [Related]
13. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. Tsuchida T; Lee YA; Fujiwara N; Ybanez M; Allen B; Martins S; Fiel MI; Goossens N; Chou HI; Hoshida Y; Friedman SL J Hepatol; 2018 Aug; 69(2):385-395. PubMed ID: 29572095 [TBL] [Abstract][Full Text] [Related]
14. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study. Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892 [TBL] [Abstract][Full Text] [Related]
15. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis. Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434 [TBL] [Abstract][Full Text] [Related]
16. Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine. Kishida N; Matsuda S; Itano O; Shinoda M; Kitago M; Yagi H; Abe Y; Hibi T; Masugi Y; Aiura K; Sakamoto M; Kitagawa Y BMC Gastroenterol; 2016 Jun; 16(1):61. PubMed ID: 27296438 [TBL] [Abstract][Full Text] [Related]
17. Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease. Li X; Wang Z; Klaunig JE Toxicology; 2018 Dec; 410():199-213. PubMed ID: 30120929 [TBL] [Abstract][Full Text] [Related]
18. Cyclophilin D knockout significantly prevents HCC development in a streptozotocin-induced mouse model of diabetes-linked NASH. Stauffer WT; Bobardt M; Ure DR; Foster RT; Gallay P PLoS One; 2024; 19(4):e0301711. PubMed ID: 38573968 [TBL] [Abstract][Full Text] [Related]
19. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease. Zhang H; Léveillé M; Courty E; Gunes A; N Nguyen B; Estall JL Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E863-E876. PubMed ID: 32924526 [TBL] [Abstract][Full Text] [Related]
20. Lactobacillus acidophilus suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma through producing valeric acid. Lau HC; Zhang X; Ji F; Lin Y; Liang W; Li Q; Chen D; Fong W; Kang X; Liu W; Chu ES; Ng QW; Yu J EBioMedicine; 2024 Feb; 100():104952. PubMed ID: 38176203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]